These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. High-dose ifosfamide in the treatment of advanced soft tissue sarcomas. Tursz T Semin Oncol; 1996 Jun; 23(3 Suppl 7):34-9. PubMed ID: 8711500 [TBL] [Abstract][Full Text] [Related]
24. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic. Demetri GD; Elias AD Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240 [TBL] [Abstract][Full Text] [Related]
25. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update. Ettinger DS Semin Oncol; 1995 Feb; 22(1 Suppl 2):23-7. PubMed ID: 7846538 [TBL] [Abstract][Full Text] [Related]
26. Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience. Benjamin RS; Legha SS; Patel SR; Nicaise C Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S174-9. PubMed ID: 8453693 [TBL] [Abstract][Full Text] [Related]
27. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma. Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084 [No Abstract] [Full Text] [Related]
28. The role of ifosfamide in small cell lung cancer. Loehrer PJ Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501 [TBL] [Abstract][Full Text] [Related]
29. The role of ifosfamide in testicular cancer. Schmoll HJ Semin Oncol; 1989 Feb; 16(1 Suppl 3):82-95. PubMed ID: 2649987 [TBL] [Abstract][Full Text] [Related]
30. The bioavailability of oral and intravenous ifosfamide in the treatment of bronchogenic carcinoma. McNiel NO; Morgan LR Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):490-3. PubMed ID: 7298241 [TBL] [Abstract][Full Text] [Related]
31. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
32. Ifosfamide and Mesna in advanced malignancies. Li GC; Brock N; Li JQ; Guan ZZ; He YJ Chin Med J (Engl); 1988 Mar; 101(3):213-20. PubMed ID: 3136996 [No Abstract] [Full Text] [Related]
33. High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone. Demetri GD Semin Oncol; 1996 Jun; 23(3 Suppl 6):22-6. PubMed ID: 8677444 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)]. Hoefer H; Scheef W; Titscher R; Kokron O Osterr Z Onkol; 1974; (1):3-7. PubMed ID: 4619650 [No Abstract] [Full Text] [Related]
35. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Sládek NE; Kollander R; Sreerama L; Kiang DT Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911 [TBL] [Abstract][Full Text] [Related]
36. Ifosfamide in paediatric oncology: tried but not tested? Shaw PJ; Eden T Lancet; 1990 Apr; 335(8696):1022-3. PubMed ID: 1970073 [No Abstract] [Full Text] [Related]
38. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS). Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM; Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685 [TBL] [Abstract][Full Text] [Related]
39. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen. Schütte J; Kellner R; Seeber S Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697 [TBL] [Abstract][Full Text] [Related]